Package Leaflet: Information for the User
Epiduo 1 mg/g + 25 mg/g Gel
Adapalene / Benzoyl Peroxide
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Epiduo is used for the treatment of acne.
This gel is a combination of two active substances, adapalene and benzoyl peroxide, which work together but have different mechanisms of action:
Adapalene belongs to a group of products known as retinoids and acts specifically on the skin processes that cause acne.
The other active substance, benzoyl peroxide, acts as an antimicrobial agent and softens and sheds the outermost layer of the skin.
Do not use Epiduo:
Warnings and precautions
Consult your doctor or pharmacist before using Epiduo
Using Epiduo and other medicines:
Pregnancy and breastfeeding:
Do not use Epiduo if you are pregnant or plan to become pregnant. Your doctor may give you more information. If you become pregnant while using Epiduo, treatment should be discontinued and you should inform your doctor as soon as possible for follow-up.
Epiduo can be used during breastfeeding. To avoid contact exposure to the infant, Epiduo should not be applied to the breast.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Not applicable
Epiduo contains propylene glycol
This medicine contains 40 mg of propylene glycol (E1520) in each unit dose equivalent to 40 mg/g.
Epiduo contains polysorbates
Polysorbates may cause allergic reactions.
Follow exactly the instructions of administration of this medicine indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.
Epiduo should only be used in adults, adolescents, and children from 9 years of age.
This medicine is for external use only.
Apply a thin layer of gel evenly over the affected areas of acne once a day before bedtime, avoiding the eyes, lips, and nostrils. The skin should be clean and dry before application. You should wash your hands carefully after using Epiduo.
Your doctor will indicate how long you need to use Epiduo.
If you think the action of Epiduo is too strong or too weak, tell your doctor or pharmacist.
If you suffer from persistent irritation when applying Epiduo, contact your doctor.
You may be advised to apply a moisturizing product, use the gel less frequently, stop using it for a short period, or stop using it altogether.
If you use more Epiduo than you should
If you use more Epiduo than you should on the skin, it will not cure your acne more quickly and your skin may become irritated and red.
Contact your doctor or hospital:
Your doctor will indicate what measures should be taken.
If you forget to use Epiduo
Do not apply a double dose to make up for forgotten individual doses.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop using the product and consult your doctor immediately if you develop tightness in the throat or swelling of the eyes, face, lips, or tongue, if you feel weak or have difficulty breathing. Stop using the product if you develop hives or itching on the face or body. These side effects occur with an unknown frequency.
Common(may affect up to 1 in 10 people).
Uncommon(may affect up to 1 in 100 people).
Frequency not known(frequency cannot be estimated from the available data): swelling of the face, allergic contact reactions, swelling of the eyelids, tightness in the throat, pain in the skin (stinging), blisters (vesicles), difficulty breathing, discoloration of the skin (change in skin color), burning at the application site.
If skin irritation occurs after applying Epiduo, it is usually mild to moderate, with local signs of redness, dryness, peeling, burning, and stinging, with a peak during the first week and resolving without additional treatment.
Burning at the application site has been reported, mostly superficial but also more severe cases involving the appearance of blisters.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton. The expiry date is the last day of the month stated.
Discard the tube or the multidose container with airless pump 6 months after first opening.
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Epiduo
The active substances are adapalene and benzoyl peroxide. 1 g of gel contains 1 mg (0.1%) of adapalene and benzoyl peroxide hydrate, equivalent to 25 mg (2.5%) of anhydrous benzoyl peroxide.
The other ingredients are sodium docusate, disodium edetate, glycerol, poloxamers, propylene glycol (E1520), Simulgel 600 PHA (acrylamide/sodium acryloyldimethyltaurate copolymer, isohexadecane, polysorbate 80 (E433), sorbitan oleate), and purified water.
Appearance and pack size of the product:
Epiduo is a white to very pale yellow opaque gel.
Epiduo is available in:
White plastic tubes with screw cap of 5g, 15g, 30g, 45g, 60g, or 90g (not all pack sizes may be marketed).
White airless pump multidose containers of 15g, 30g, 45g, and 60g (not all pack sizes may be marketed).
Marketing authorisation holder:
Laboratorios Galderma, S.A.
Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer:
Laboratoires Galderma
Z.I.- Montdésir
74540, Alby-sur-Chéran
France
or
Galderma Laboratorium Gmbh
Toulouser Allee 23a
40211 Düsseldorf
Germany
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Denmark: Epiduo
Croatia, Czech Republic, Portugal, Slovakia, Spain: Epiduo 1 mg/g + 25 mg/g gel
Hungary, Netherlands: Effezel 1 mg/g + 25 mg/g gel
Bulgaria, Estonia, Latvia, Lithuania, Romania: Epiduo 1 mg/25 mg/g gel
Slovenia: Epiduo 1 mg/25 mg in 1 g gel
Other countries: Epiduo 0.1%/2.5% gel
This leaflet was approved in: October 2024
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es